
|Slideshows|June 28, 2018
Insulin Discontinuation and Other Measures of GLP-1 RA Efficacy
Author(s)Kenneth J. Bender, PharmD, MA
What is the impact on insulin dose, A1c, body weight of adding GLP-1 RA to a MDI insulin regimen? Three studies from ADA 2018 illuminate.
Advertisement
Newsletter
Enhance your clinical practice with the Patient Care newsletter, offering the latest evidence-based guidelines, diagnostic insights, and treatment strategies for primary care physicians.
Advertisement
Latest CME
Advertisement
Advertisement
Trending on Patient Care Online
1
FDA Approves GSK's Depimokimab for Severe Asthma with Th2 Inflammation, First Ultra-Long Acting Biologic
2
After ACIP Debate, CDC Modifies Longstanding Hepatitis B Birth Dose Recommendation
3
Colorectal Cancer Screening in 2025: What Changed, and What Didn't, with Mark Fendrick, MD
4
Key Advances in Mental Health Research in 2025 for Primary Care
5
















































































































































































































































































